Position in EBS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,396,915
+$1,289,920 QoQ
Shares Held
409,267
+140.1% QoQ
Ownership
0.798%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 81%
Shared 0%
None 19%
Common Shares in EBS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Ancora Advisors LLC holds $44,062 across 5 Drug Manufacturers - Specialty & Generic names.
All Filings in EBS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,396,915 | 409,267 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,106,995 | 170,469 | Shares | Sole | 2026-02-17 | |
| 2021-09-30 | $4,005 | 80 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $10,708 | 170 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $65,966 | 710 | Shares | Sole | 2021-11-12 | |
| 2020-12-31 | $2,510,502 | 28,019 | Shares | Sole | 2021-11-12 | |
| 2020-09-30 | $1,840,203 | 17,809 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $2,531,192 | 32,008 | Shares | Sole | 2021-11-12 | |
| 2020-03-31 | $1,181,385 | 20,418 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||